Efficacy and Safety of Lanthanum Carbonate and Sevelamer Hydrochloride in Patients Receiving Haemodialysis for End Stage Renal Disease
Completed
Shire
Phase 3
2005-01-07
The purpose of this study is to assess phosphate reduction and control in patients with End
Stage Renal Disease treated with either lanthanum carbonate or sevelamer hydrochloride
Study to Demonstrate Equivalence of Sevelamer Carbonate Powder and Sevelamer HCl Tablets in Haemodialysis Patients
Completed
Genzyme, a Sanofi Company
Phase 3
2006-01-01
The purpose of this study is to determine if sevelamer carbonate powder is an effective
treatment for the control of serum phosphorous levels in patients on dialysis when compared
to sevelamer hydrochloride tablets.
Study to Compare Sevelamer Carbonate Powder to Sevelamer Hydrochloride Tablets in Patients With CKD on Hemodialysis
Completed
Genzyme, a Sanofi Company
Phase 3
2006-01-01
Approximately 207 patients with chronic kidney disease (CKD) on hemodialysis will be entered
into this study at approximately 26 centers in the United States. This study aims to evaluate
the safety and efficacy of sevelamer carbonate powder dosed once-a-day (QD) with the largest
meal compared to sevelamer hydrochloride tablets dosed three-times-per-day (TID) with meals.
The total length of participation is approximately 24 weeks.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
